Fortvita Biologics (USA)Inc. clinical trials
A country office of Innovent Biologics, Inc.
The registry lists 5 studies whose lead sponsor is Fortvita Biologics (USA)Inc.. 5 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 25, 2026.
Registry sponsor names on this page
- Fortvita Biologics (USA)Inc.5 studies
Something wrong with this grouping? Tell us on the Innovent Biologics, Inc. page.
Studies
Recruiting first, then most recently updated. Showing 5 of 5. All Innovent Biologics, Inc. studies →
- IBI3001 in Participants With Unresectable, Locally Advanced or Metastatic Solid TumorsRecruitingNCT06349408Phase 1
Sponsor listed in the registry: Fortvita Biologics (USA)Inc.
- Study of IBI3020 Treatment in Participants With Late-Stage Solid TumorsRecruitingNCT06963281Phase 1
Sponsor listed in the registry: Fortvita Biologics (USA)Inc.
- A Study of IBI3003 in Subjects With Relapsed or Refractory Multiple MyelomaRecruitingNCT07336472Phase 1/2
Sponsor listed in the registry: Fortvita Biologics (USA)Inc.
- A Study of IBI3042 in Healthy Adult ParticipantsNot yet recruitingNCT07842393Phase 1
Sponsor listed in the registry: Fortvita Biologics (USA)Inc.
- A Study of IBI3032 in Healthy ParticipantsRecruitingNCT07120425Phase 1
Sponsor listed in the registry: Fortvita Biologics (USA)Inc.